Yutiq is a medicine used to treat chronic non-infectious uveitis. The drug is put into the eye and works slowly to release a substance that reduces inflammation, thereby reducing the symptoms of the disease.

Brolucizumab medicine has the main ingredient Brolucizumab, commonly used in the treatment of macular degeneration in the eyes. In addition to the therapeutic effect, patients using Brolucizumab may experience some unwanted effects such as blurred vision, cataracts, eye pain...

The incubation period for pink eye is about 8 days on average, and the illness lasts several days, weeks, or longer, depending on the cause and treatment.

Endophthalmitis is a serious eye infection whose prognosis depends largely on the timing of diagnosis and appropriate treatment. Endophthalmitis is often caused by pathogens such as bacteria and fungi that can enter the eye directly through damage to the eye.

Sudden blurred vision can make it difficult to see clearly or perform everyday tasks. While not all cases are cause for concern, some may require prompt medical attention.